Cargando…
Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients
BACKGROUND: Eligibility criteria and endpoints for cancer cachexia trials—and whether weight loss should be included—remain controversial. Although most cachexia trials enrol patients after initial cancer diagnosis, few studies have addressed whether weight loss well after a cancer diagnosis is prog...
Autores principales: | Le‐Rademacher, Jennifer, Lopez, Camden, Wolfe, Eric, Foster, Nathan R., Mandrekar, Sumithra J., Wang, Xiaofei, Kumar, Rajiv, Adjei, Alex, Jatoi, Aminah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749536/ https://www.ncbi.nlm.nih.gov/pubmed/32940014 http://dx.doi.org/10.1002/jcsm.12625 |
Ejemplares similares
-
Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical Trials
por: Le-Rademacher, Jennifer G., et al.
Publicado: (2019) -
Remarks on the design and analyses of longitudinal studies for cancer patients with anorexia and weight loss
por: Le‐Rademacher, Jennifer G., et al.
Publicado: (2019) -
Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials
por: Le-Rademacher, Jennifer G., et al.
Publicado: (2020) -
Patients’ rationale for declining participation in a cancer-associated weight loss study
por: Wanger, Tammy, et al.
Publicado: (2014) -
Succinct Cancer Clinical Trial Consent Forms in Rural Patients With Cancer: A Secondary Analysis of a Randomized, Double-Blinded study
por: Wieland, Jana, et al.
Publicado: (2022)